Top Factor Driving Vitamin D Therapy Market Growth in 2025: The Surge In Vitamin D Therapy Market Fueled By The Rising Prevalence Of Malnutrition

Which drivers are expected to have the greatest impact on the over the vitamin d therapy market's growth?
The projected rise in malnutrition cases is likely to fuel the expansion of the vitamin D therapy market. Malnutrition is characterized by inadequate or excessive nutrient intake, nutrient imbalances, or hindered nutrient utilization. It is found that vitamin D deficiency is extremely common in hospitalized malnourished patients and is inversely related to long-term mortality, especially when patients are not undergoing vitamin D therapy. Consequently, the growing occurrence of malnutrition cases necessitates vitamin D therapy. For instance, the World Health Organization, a Switzerland-based health-promoting, global safety, and vulnerability-serving agency, reported in March 2024 that in 2022, about 390 million adults globally aged 18 years and older were underweight, while 2.5 billion were overweight, including 890 million who were obese. Among children and adolescents aged between 5-19 years, 390 million were overweight, including 160 million who were obese. Additionally, 190 million were thin, and an estimated 149 million children below the age of 5 years were stunted, while 37 million were overweight or obese. Almost half of the deaths among children below 5 years of age are attributed to undernutrition. Hence, the surge in malnutrition cases is stimulating the growth of the vitamin D therapy market.

Get Your Vitamin D Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report

What is the future CAGR of the vitamin d therapy market, and how will it impact industry expansion?
The size of the vitamin D therapy market has seen a swift expansion in the last few years, surging from $2.92 billion in 2024 to an anticipated $3.27 billion in 2025. This constitutes a compound annual growth rate (CAGR) of 12.1%. Several factors have fueled this growth during the historical period, including an elevated awareness of Vitamin D deficiency, a rise in bone disorder incidents, an ageing demographic, prevalent osteoporosis, the highlighting of benefits through scientific investigation, an upturn in diseases related to lifestyle habits, and medical guidance promoting supplementation.

Anticipated to witness accelerated growth in the approaching years, the vitamin D therapy market is estimated to expand to $5.44 billion by 2029 with a compound annual growth rate (CAGR) of 13.6%. This growth during the predicted period can be ascribed to ongoing awareness and educational initiatives, a growing senior citizen population, vitamin D's incorporation in the treatment of chronic illnesses, advancements in formulation technologies, worldwide health campaigns, and a heightened emphasis on individual nutrition. The upcoming period's key trends encompass broadening uses beyond supporting bone health, governmental programs endorsing supplementation, breakthroughs in formulation and delivery techniques, a shift towards clinical research and evidence-based practices, along with the global market's expansion.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp

What are the most significant trends transforming the vitamin d therapy market today?
A trend that is currently gaining traction in the vitamin D therapy market is product innovation. To maintain their market positions, major firms in this sector are rolling out inventive products. For instance, Cadila Pharmaceuticals Pvt Ltd., a multinational pharmaceutical company based in India, set a new precedent in Vitamin D deficiency therapy with the debut of its first aqueous formulation in February 2024, aptly named Aqueous Cholecalciferol Injection by Cadila Pharmaceuticals. This cutting-edge innovation offers a quick fix for Vitamin D deficiency in a short duration and boasts superior pharmacokinetics (PK) and pharmacodynamics (PD) compared to the conventional oil-based cholecalciferol preparations available in the market.

Which key market segments comprise the vitamin d therapy market and drive its revenue growth?
The vitamin d therapy market covered in this report is segmented -

1) By Administration: Oral, Parenteral
2) By Purchasing: OTC Drugs, Prescription Drugs
3) By Age Group: Children, Adults, Senior Adults
4) By Application: Osteoporosis, Rickets, Skin Diseases, Muscle Weakness, Autoimmune Disorders

Subsegments:
1) By Oral: Vitamin D3 Supplements (Cholecalciferol), Vitamin D2 Supplements (Ergocalciferol), Vitamin D Fortified Foods And Beverages
2) By Parenteral: Injectable Vitamin D3 (Cholecalciferol), Injectable Vitamin D2 (Ergocalciferol), Intravenous Vitamin D Preparations

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8810

What regions are at the forefront of vitamin d therapy market expansion?
North America was the largest region in the vitamin D therapy market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitamin D therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the leading players fueling growth in the vitamin d therapy market?
Major companies operating in the vitamin d therapy market are Abbott Laboratories, Sanofi SA, GlaxoSmithKline PLC, Pfizer Inc., Merck & Co Inc., Torrent Pharmaceuticals Ltd., Novartis International AG, Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., Biotics Research Corporation, Solvay Pharma India Pvt. Ltd., Forgo Pharmaceuticals Ltd., Mankind Pharmaceuticals Pvt. Ltd., Cipla Ltd., Ortho Molecular Products, Zhejiang Garden Biochemical High-tech Co. Ltd., Glenmark Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Emcure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Lupin Ltd., Macleods Pharmaceuticals Ltd., Mylan N.V., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Biocare Medical LLC, Mitsubishi Chemical Group, Zydus Cadila, DSM Nutritional Products AG, BASF SE, Fermenta Biotech Ltd., Taizhou Hisound Pharmaceutical Co. Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8810&type=smp

What Is Covered In The Vitamin D Therapy Global Market Report?

• Market Size Forecast: Examine the vitamin d therapy market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the vitamin d therapy market for a structured understanding.
• Key Players Overview: Analyze major players in the vitamin d therapy market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the vitamin d therapy market.
• Segment Contributions: Evaluate how different segments drive overall growth in the vitamin d therapy market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the vitamin d therapy market.
• Industry Challenges: Identify potential risks and obstacles affecting the vitamin d therapy market.
• Competitive Landscape: Review strategic developments in the vitamin d therapy market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.